Connect with us

Medical Research

Indian Government, CIMAP and Finance Ministry Green Light Cannabis Seed Oil Research 

Luice Syed

Published

on

Indian Government, CIMAP and Finance Ministry Green Light Cannabis Seed Oil Research

 The drug law enforcement agency of India, Narcotics Control Bureau within the revenue wing of the Union Finance Minister, has authorized a research and development (R&D) program on Cannabidiol (CBD) and Tetrahydrocannabinol (THC), the two naturally found compounds in the Cannabis plant.

The project is undertaken by the Central Institute of Medicinal And Aromatic Plants (CIMAP) and is going to explore the cultivation of low THC high CBD Cannabis strains at their office in Lucknow (Uttar Pradesh) and resource center in Pantnagar (Uttarakhand). 

The Council of Scientific & Industrial Research (CSIR), together with CIMAP will start R&D work on genetic improvement of identification and selection of THC, CBD, and Cannabinioderpene– a rich strain-level genetic constituent of Ganja.

CBD is a non-psychoactive medicinal compound that has several therapeutic values whereas THC is the psychoactive component of Ganja that gives the “high” when consumed. Industrial Marijuana or Hemp can be refined for use in many commercial commodities like paper, textile, clothing, paint, biofuel, and animal feed.

It’s not just the beverage companies now that have interest in Cannabis. The trend is extending to health, beauty and wellness products as well. With new legislation on R&D of Cannabis plant, India will open up splendid opportunities to tap into the ready-to-boom Cannabis economy worldwide.

Luice resides in Pune, India and has recently taken up a kinship with freelance writing. For the past few years, he has been working at Springer Nature in the field of Nanobiotechnology. When not analyzing medical literature and scientific research data, Luice enjoys watching and playing football as well as going on a long hike.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Follow Times of CBD News

popular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD.com is the most active daily cannabis news publication online inviting all readers to come for the headlines and stay for the insights. The primary focus is on curating latest CBD news updates, marijuana market movements and researched hemp-based product user guides. While everything is here for educational, informational purposes only, quality is always the priority and fact checking sources with industry-leading accuracy in reporting is at the top of the list of this emerging, innovative industry.

Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

Got news? Email us [email protected]

Trending Cannabis News

Advertisement